CD4 and Stroke: In IS, preclinical studies with mice lacking CD84 receptor on platelets or T cells, impairing activation, displayed reduced cerebral CD4+ T-cell infiltration and thrombotic activity following experimental stroke resulting in reduced neurological damage.